Evidence map›Paper›PMID 41845493›Full record

ArticleAlzheimer's research & therapy2026

Impact of diagnostic genetic testing for familial dementia: experiences of patients and relatives.

Jetske van der Schaar, Leonie N C Visser, Eva C A Asscher, Yolande A L Pijnenburg, Christa M de Geus, Wiesje M van der Flier, Annelien L Bredenoord, Mariette A van den Hoven, Ellen M A Smets, Sven J van der Lee

Abstract read
In one paragraph

Article in Alzheimer's research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jetske van der SchaarGenomics of Neurodegenerative Diseases and Aging, Department of Human Genetics, Amsterdam UMC location VUmc, Amsterdam, The Netherlands. jetske.vanderschaar@amsterdamumc.nl.
Leonie N C VisserDepartment of Medical Psychology, Amsterdam UMC location AMC, Amsterdam, The Netherlands.
Eva C A AsscherDepartment of Ethics, Law and Humanities, Amsterdam UMC, Amsterdam, The Netherlands.
Yolande A L PijnenburgAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
Christa M de GeusClinical Genetics, Department of Human Genetics, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
Wiesje M van der FlierNeurodegeneration, Amsterdam Neuroscience, Amsterdam, The Netherlands.
Annelien L BredenoordErasmus School of Philosophy, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Mariette A van den HovenDepartment of Ethics, Law and Humanities, Amsterdam UMC, Amsterdam, The Netherlands.
Ellen M A SmetsDepartment of Medical Psychology, Amsterdam UMC location AMC, Amsterdam, The Netherlands.
Sven J van der LeeGenomics of Neurodegenerative Diseases and Aging, Department of Human Genetics, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.

Funding

Health∼Holland, Topsector Life Sciences & Health LSHM20106Nederlandse Organisatie voor Wetenschappelijk Onderzoek 733050512ZonMw 73305095007
6 · The paper itself

Abstract

backgroundWhile memory clinic patients express interest in diagnostic genetic testing for monogenic causes of dementia, its personal consequences remain unclear. We explored the psychosocial and behavioral impact on patients and relatives.

methodsIn this mixed-methods study, we examined 31 patients meeting eligibility criteria for genetic testing as part of their diagnostic work-up at Alzheimer Center Amsterdam. Patients were 45% female, and aged 61 ± 8 (MMSE = 23 ± 5, 25 dementia [15 AD, 4 PPA, 6 other], 1 MCI, 1 SCD, 4 other/undetermined). Twenty-five tested negative, and six positive. Per case, either the patient, one or more relatives, or both were included (3/31 patient only; 5/31 relative(s) only; 23/31 both), yielding 26 patients and 29 relatives (55% female, and aged 54 ± 12). Participants completed questionnaires assessing psychosocial and behavioral factors at first visit, one week post-counseling, and one week and three months post-disclosure. We used linear mixed models to calculate effects of group, time, and interaction, with patients and relatives analyzed separately. In addition, 8 patients and 10 relatives participated in 13 semi-structured interviews, analyzed inductively.

resultsAverage anxiety, depression and distress levels remained below clinical threshold in patients and relatives. Anxiety was lower in patients one week and three months post-disclosure, and lower in relatives one week post-disclosure. At baseline, positive patients reported lower social support, and over time they discussed genetic testing less often with others. Positive patients more often reported having registered for research participation. Patients’ decision regret was low and independent of group. Interviews revealed that participants receiving negative results felt relieved their offspring were not at genetic risk, but some remained uncertain about the cause of their disease. Those receiving positive results experienced emotional distress about potential implications for their children, yet appreciated having clarity. Participants related to positive cases described challenges in receiving emotional support.

conclusionsWhile diagnostic genetic testing was well tolerated and valued, it also revealed complex emotional, relational, and practical consequences for patients and families, indicating a need for psychosocial support. As this was an exploratory study, findings should be interpreted cautiously and validated in future research.

Indexed as

DementiaFamilyGenetic TestingAdultAgedAnxietyFemaleHumansMaleMiddle AgedSurveys and QuestionnairesAlzheimer’s diseaseBehavioral impactDna-diagnosticsFamilial dementiaFrontotemporal dementiaGenetic testingLewy body dementiaMonogenic causesPathogenic mutationsPatient experiencePsychosocial impactRegretSymptomatic testingUnderstandingVascular dementia

Identifiers

PMID41845493
PMCPMC13107723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.